Global energy markets are on edge as Middle East conflicts keep oil prices high and inflation risks alive. For Indian growth stocks, that backdrop puts extra focus on companies that can grow earnings without relying on cheap money or fragile balance sheets. This article looks at three stocks from a screen of financially solid Indian companies where analysts currently expect strong earnings growth over the next few years.
The three stocks that follow are just a starting sample, since the full screen surfaced 134 more companies with similarly strong growth expectations and solid balance sheets that are not covered here. If you want to go wider and identify the ideas that best match your risk profile and time horizon, head straight into the Healthy high growth potential screener.
Overview: Monolithisch India manufactures and supplies ramming mass, a refractory material used as heat insulation and furnace lining in induction furnaces for steel, metallurgy and foundry plants in India and Nepal. This directly links its growth to heavy industrial production. That gives the company clear exposure to the “Healthy high growth potential” theme, as these end markets are where analysts currently expect strong earnings expansion.
Operations: Monolithisch India generates its revenue almost entirely from the production of ramming mass and related products, which brought in about ₹1,538 million in the latest reported period.
Market Cap: ₹27.5 billion
Monolithisch India is worth a closer look if you want exposure to heavy industry growth without owning steelmakers themselves. The company’s ramming mass is a recurring consumable for induction furnaces, and recent numbers show earnings growing faster than revenue as margins improve and return on equity sits in the low 20s. That growth profile has attracted a premium P/E multiple, which heightens the risk if expectations cool or funding pressures from external borrowing increase. At the same time, experienced directors and regular financial reporting provide a clearer read on whether current growth forecasts remain on track.
Monolithisch India’s fast expanding earnings and premium P/E raise a clear question: Are margins and returns as durable as they look, or is there a pressure point investors are missing in the analysis report for Monolithisch India
Overview: Shaily Engineering Plastics develops and manufactures precision plastic components and specialty drug delivery devices such as inhalers, auto injectors and insulin pens for global pharmaceutical clients, while also supplying consumer, automotive and personal care products. Its contract development and manufacturing work for pharma, particularly in high value devices, is the clearest link to the Healthy high growth potential theme, which is associated with expectations of strong earnings growth from healthcare focused outsourcing.
Operations: Shaily Engineering Plastics generates its revenue primarily from customised components of plastic and other materials, which contributed about ₹10,246 million in the latest reported period.
Market Cap: ₹150.7 billion
Shaily Engineering Plastics may merit attention if you want exposure to healthcare devices through a contract manufacturer that already works with multinational clients and exports to around 40 countries. Earnings and revenue growth forecasts are currently positive, margins and return on equity are currently healthy, and recent quarterly results showed further progress in both revenue and net income. However, the stock trades on a rich valuation, relies heavily on external borrowings and is investing aggressively in new capacity for GLP 1 and other pen platforms where demand and utilisation are not yet fully proven. The full story lies in how that new capacity, export exposure and higher margin healthcare mix evolve over the coming periods.
Shaily Engineering Plastics is increasingly focusing on high value drug delivery devices, while carrying a rich valuation and making fresh capacity bets. Get the full picture in the analyst forecasts for Shaily Engineering Plastics and see what the headline numbers may be masking.
Overview: Schneider Electric Infrastructure designs and supplies medium voltage equipment, transformers and digital grid automation systems that help utilities and infrastructure operators manage electricity distribution, including its EcoStruxure Grid and related software platforms that link most directly to the Healthy high growth potential theme through software defined grid upgrades and battery storage projects.
Operations: Schneider Electric Infrastructure generates its revenue primarily from Product and Systems for Electricity Distribution, which contributed about ₹29,204 million in the latest reported period.
Market Cap: ₹294.7 billion
Schneider Electric Infrastructure may appeal to investors who want exposure to digital grid upgrades and energy management rather than only traditional power equipment. Analysts have highlighted earnings growth potential from EcoStruxure Grid, distribution management systems and battery storage work. At the same time, recent margin pressure and earnings that declined 29.5% over the past year illustrate how sensitive profits can be when high price-to-sales expectations meet project based revenue. Capacity expansions in Kolkata and Vadodara, together with rising demand from data centers, renewables and metro rail, indicate a larger installed base that could support higher margin software and services. A key consideration is whether earnings, cash generation and governance will align with the growth profile that investors are currently paying for.
Schneider Electric Infrastructure’s grid software story often gets overshadowed by the headline hardware. Analysts are already modelling the next leg of earnings growth in the analyst forecasts for Schneider Electric Infrastructure, yet one key swing factor still looks underappreciated.
Fresh ideas move first. Markets can reward investors who catch quiet breakouts and early momentum while information is still under the radar for now. Do not wait; act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com